Bridgepoint Group (LON:BPT) Shares Down 9.6% – Here’s What Happened

Bridgepoint Group plc (LON:BPTGet Free Report) shares traded down 9.6% on Wednesday . The stock traded as low as GBX 240.60 and last traded at GBX 240.80. 6,589,081 shares were traded during mid-day trading, a decline of 18% from the average session volume of 8,079,381 shares. The stock had previously closed at GBX 266.40.

Analyst Ratings Changes

Separately, Citigroup lowered their price target on shares of Bridgepoint Group from GBX 415 to GBX 395 and set a “buy” rating for the company in a research report on Tuesday, April 14th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of GBX 385.

Get Our Latest Research Report on BPT

Bridgepoint Group Trading Down 9.8%

The stock’s fifty day simple moving average is GBX 253.15 and its 200-day simple moving average is GBX 264.63. The firm has a market cap of £2.10 billion, a PE ratio of 49.02, a PEG ratio of 0.61 and a beta of 1.36. The company has a debt-to-equity ratio of 55.04, a current ratio of 279.03 and a quick ratio of 3.60.

Bridgepoint Group (LON:BPTGet Free Report) last posted its quarterly earnings results on Thursday, March 12th. The company reported GBX 26.50 earnings per share (EPS) for the quarter. Bridgepoint Group had a net margin of 7.68% and a return on equity of 4.25%. On average, sell-side analysts forecast that Bridgepoint Group plc will post 17.4062165 earnings per share for the current year.

Insider Activity

In other news, insider Michelle Scrimgeour acquired 21,616 shares of Bridgepoint Group stock in a transaction dated Thursday, March 12th. The stock was purchased at an average cost of GBX 230 per share, for a total transaction of £49,716.80. 0.60% of the stock is currently owned by insiders.

Bridgepoint Group Company Profile

(Get Free Report)

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.

Recommended Stories

Receive News & Ratings for Bridgepoint Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bridgepoint Group and related companies with MarketBeat.com's FREE daily email newsletter.